Applicant, as named in the Orange Book

Glaxosmithkline

Next listed expiry: Anoro Ellipta on 29 Nov 2030. 7 products with live protection, 12 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Anoro Ellipta umeclidinium bromide; vilanterol trifenatate	umeclidinium bromide; vilanterol trifenatate	203975	29 Nov 2030	patent
Trelegy Ellipta · 2 strengths fluticasone furoate; umeclidinium bromide; vilanterol trifenatate	fluticasone furoate; umeclidinium bromide; vilanterol trifenatate	209482	11 Apr 2031	patent
Utebzi tebipenem pivoxil hydrobromide	tebipenem pivoxil hydrobromide	215960	6 Feb 2038	patent
Zejula · 3 strengths niraparib tosylate	niraparib tosylate	214876	25 Jan 2039	patent
Brexafemme ibrexafungerp citrate	ibrexafungerp citrate	214900	10 Jun 2039	patent, carve-out possible
Ojjaara · 3 strengths momelotinib dihydrochloride	momelotinib dihydrochloride	216873	2 Dec 2040	patent, carve-out possible
Blujepa gepotidacin mesylate	gepotidacin mesylate	218230	13 Dec 2042	patent

Recent events

25 Oct 2026Thorazine · Generic approved 10 Oct 2025
25 Oct 2026Bactroban · Generic approved 29 Sep 2026
25 Oct 2026Thorazine · Generic approved 26 Jan 2026

Products without listed protection (12)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Arnuity Ellipta · 3 strengths fluticasone furoate	fluticasone furoate	205625	open now	no listed protection
Imitrex · 2 strengths sumatriptan	sumatriptan	020626	open now	no listed protection
Imitrex · 3 strengths sumatriptan succinate	sumatriptan succinate	020132	open now	no listed protection
Imitrex Statdose (Autoinjector) · 2 strengths sumatriptan succinate	sumatriptan succinate	020080	open now	no listed protection
Krintafel tafenoquine succinate	tafenoquine succinate	210795	open now	no listed protection
Malarone atovaquone; proguanil hydrochloride	atovaquone; proguanil hydrochloride	021078	open now	no listed protection
Malarone Pediatric atovaquone; proguanil hydrochloride	atovaquone; proguanil hydrochloride	021078	open now	no listed protection
Relenza zanamivir	zanamivir	021036	open now	no listed protection
Serevent salmeterol xinafoate	salmeterol xinafoate	020692	open now	no listed protection
Valtrex · 2 strengths valacyclovir hydrochloride	valacyclovir hydrochloride	020487	open now	no listed protection
Ventolin Hfa albuterol sulfate	albuterol sulfate	020983	open now	no listed protection
Wellbutrin Sr · 3 strengths bupropion hydrochloride	bupropion hydrochloride	020358	open now	no listed protection